Company / Named in our posts
ESSA Pharma Inc..
Follow ESSA Pharma Inc.ESSA is a pharmaceutical company that was previously focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.[1]
01Deal
Deals on Carrywatch
Every deal that names ESSA Pharma Inc., and its role in each.
Xeno Acquisition Corp. / ESSA Pharma Inc.
Xeno Acquisition Corp. to acquire ESSA Pharma Inc. in business combination
See deal detailsDeal Web
ESSA Pharma Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as ESSA Pharma Inc. reported them.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
- 02Form 8-K
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming ESSA Pharma Inc.:
- P01